FDA Panel Urges Stronger Antidepressant Warning

An advisory committee recommends the FDA issue stronger warnings about the use of antidepressants called SSRIs in children and teenagers. The panel concludes that available research suggests the drugs can double the incidence of suicidal thoughts and attempts. Hear NPR's Joanne Silberner.

Comments

 

Please keep your community civil. All comments must follow the NPR.org Community rules and terms of use, and will be moderated prior to posting. NPR reserves the right to use the comments we receive, in whole or in part, and to use the commenter's name and location, in any medium. See also the Terms of Use, Privacy Policy and Community FAQ.

Support comes from: